|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
TECHNOLOGY DEVELOPMENT |
Institute of Basic Medical Sciences, Department of Biochemistry, Faculty of Medicine, University of Oslo, Oslo, Norway
Key Words. Chromatin immunoprecipitation • Differentiation • Embryonal carcinoma cell • Histone acetylation • Histone methylation
Correspondence: Philippe Collas, Ph.D., Institute of Basic Medical Sciences, Department of Biochemistry, University of Oslo, PO Box 1112 Blindern, 0317 Oslo, Norway. Telephone: +4722851066; Fax: +4722851058; e-mail: philc{at}medisin.uio.no
Received on July 13, 2006;
accepted for publication on December 22, 2006.
Disclosure of potential conflicts of interest is found at the end of this article.
First published online in STEM CELLS EXPRESS February 1, 2007.
Chromatin immunoprecipitation (ChIP) is a key technique for studying protein-DNA interactions and mapping epigenetic histone modifications on DNA. Current ChIP protocols require extensive sample handling and large cell numbers. We developed a quick and quantitative (Q2)ChIP assay suitable for histone and transcription factor immunoprecipitation from chromatin amounts equivalent to as few as 100 cells. DNA-protein cross-linking in suspension in presence of butyrate, elimination of background chromatin through a tube shift after washes, and a combination of cross-link reversal, protein digestion, increased antibody-bead to chromatin ratio, and DNA elution into a single step considerably improve ChIP efficiency and shorten the procedure. We used Q2ChIP to monitor changes in histone H3 modifications on the 5' regulatory regions of the developmentally regulated genes OCT4, NANOG, LMNA, and PAX6 in the context of retinoic-acid-mediated human embryonal carcinoma cell differentiation. Quantitative polymerase chain reaction analysis of precipitated DNA unravels biphasic heterochromatin assembly on OCT4 and NANOG, involving H3 lysine (K)9 and K27 methylation followed by H3K9 deacetylation and additional H3K27 trimethylation. Di- and trimethylation of H3K4 remain relatively unaltered. In contrast, PAX6 displays histone modifications characteristic of repressed genes with potential for activation in undifferentiated cells. PAX6 undergoes H3K9 acetylation and enhanced H3K4 trimethylation upon transcriptional activation. Q2ChIP of the transcription factor Oct4 demonstrates its dissociation from the NANOG promoter upon differentiation. This study is, to our knowledge, the first to reveal histone modification changes on human OCT4 and NANOG regulatory sequences. The results demonstrate ordered chromatin rearrangement on developmentally regulated promoters upon differentiation.
This article has been cited by other articles:
![]() |
A. Golebiewska, S. P. Atkinson, M. Lako, and L. Armstrong Epigenetic Landscaping During hESC Differentiation to Neural Cells Stem Cells, June 1, 2009; 27(6): 1298 - 1308. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tilgner, S. P. Atkinson, A. Golebiewska, M. Stojkovic, M. Lako, and L. Armstrong Isolation of Primordial Germ Cells from Differentiating Human Embryonic Stem Cells Stem Cells, December 1, 2008; 26(12): 3075 - 3085. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Dahl and P. Collas {micro}ChIP--a rapid micro chromatin immunoprecipitation assay for small cell samples and biopsies Nucleic Acids Res., February 11, 2008; 36(3): e15 - e15. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Lee, F. E. Murdoch, and M. K. Fritsch High Histone Acetylation and Decreased Polycomb Repressive Complex 2 Member Levels Regulate Gene Specific Transcriptional Changes During Early Embryonic Stem Cell Differentiation Induced by Retinoic Acid Stem Cells, September 1, 2007; 25(9): 2191 - 2199. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Attema, P. Papathanasiou, E. C. Forsberg, J. Xu, S. T. Smale, and I. L. Weissman Epigenetic characterization of hematopoietic stem cell differentiation using miniChIP and bisulfite sequencing analysis PNAS, July 24, 2007; 104(30): 12371 - 12376. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |